Diabetes may be one of the nation’s leading causes of death, but knowing the facts can help you understand and avert the onset of the most common form of diabetes, type 2. Education is power to fight the deadly consequences of diabetes, and Dr. Schwartz identifies what you need to know.
Together with colleagues in Barcelona, researchers at the University of North Carolina at Chapel Hill have generated a complete map of the areas of the genome that control which genes are “turned on” or “off.” The discovery, made in pancreatic islet cells, opens new avenues for understanding the genetic basis of type 2 diabetes and other common illnesses.
While diabetes and hypertension ranked high for both groups, patients were more likely than doctors to prioritize symptoms such as pain and depression.
New collaboration leverages Joslin’s deep clinical and research expertise and dLife’s community and lifestyle approach to managing diabetes.
Type 2 diabetes is the silent killer...leading to heart disease and stroke. Some things to look out for and ways to prevent it.
In patients with type 2 diabetes, silent cerebral infarction (SCI)—small areas of brain damage caused by injury to small blood vessels—signals an increased risk of progressive kidney disease and kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
A new treatment that could one day benefit burns victims, diabetes sufferers and the elderly – by fast tracking the healing of chronic wounds – has taken another step toward commercialization.
Clinical and basic science researchers from around the world will convene in Hong Kong from January 28 to 30 for the First International Congress on Abdominal Obesity: “Bridging the Gap between Cardiology and Diabetology.” The congress, sponsored by the International Chair on Cardiometabolic Risk (ICCR) (www.cardiometabolic-risk.org), is the first-ever specialized forum for sharing new insights and evidence about abdominal obesity and its clinical and public health implications.
In people who put on a lot of weight, or whose bodies start developing the inability to use insulin effectively that leads toward type 2 diabetes, the pancreas typically ramps up its supply of insulin-generating “beta” cells. Researchers at Joslin Diabetes Center and their colleagues now have identified a cell-cycle protein that is essential for beta-cell replication to respond successfully to insulin resistance. The finding may point toward eventual therapies for preventing or treating type 2 diabetes.
The neuropeptide corticotropin-releasing factor (CRF) makes cameo appearances throughout the body, but its leading role is as the opening act in the stress response, jump-starting the process along the hypothalamus-pituitary-adrenal (HPA) axis. Researchers at the Salk Institute for Biological Studies have found that CRF also plays a part in the pancreas, where it increases insulin secretion and promotes the division of the insulin-producing beta cells.
Patients who ordered their medications by mail were more likely to take them as prescribed by their physicians than patients who obtained medications from a local pharmacy.
A new evidence review suggests that using a pump to deliver insulin continuously — instead of taking three or more daily injections — might result in better control of blood sugar for people with type 1 diabetes.
Obstructive Sleep Apnea (OSA) adversely affects glucose control in patients with type 2 diabetes, according to a study conducted by researchers at the University of Chicago.
The cardiovascular risk that is associated with proteinuria, or high levels of protein in the urine, a common test used by doctors as an indicator of increased risk for progressive kidney disease, heart attack and stroke, has race-dependent effects, according to a new study by researchers at Wake Forest University School of Medicine.
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits.
A multi-disciplinary team of Penn researchers, including diabetes, weight loss and bariatric surgery experts, are conducting a study funded by the National Institutes of Health (NIH) to determine if bariatric surgery, either gastric bypass or adjustable gastric banding surgery, is more effective than lifestyle modification to reduce weight and ultimately treat Type 2 diabetes.
Bariatric surgery is a procedure designed to help patients lose weight, but what may be even more important is that it can also help resolve diabetes for patients with this disease.
Cigarette smoking is a well-known risk factor for type 2 diabetes, but new research from Johns Hopkins suggests that quitting the habit may actually raise diabetes risk in the short term.
In an annual supplement to the journal Diabetes Care, published Dec. 29 by the American Diabetes Association, the A1C test is given a prominent role in the 2010 guidelines for diabetes screening, diagnosis and prevention.
Researchers at the University of North Carolina at Chapel Hill School of Medicine say a recent discovery suggests that inherited genetic variations exist between whites and blacks living in the U.S., leading to less efficient metabolism of glucose and predisposition to diabetes in blacks.
Joslin scientists discover that high blood glucose levels damage a key enzyme that guards against oxidative stress in beta cells.
Researchers led by specialists at the Johns Hopkins Wilmer Eye Institute have found that injecting a corticosteroid, triamcinolone, directly into the eye may slow the progression of proliferative diabetic retinopathy, a complication of diabetes that frequently leads to blindness.
South Dakota State University researchers used the Native American spiritual concept of the Medicine Wheel to help bring positive changes for American Indian diabetics.
New findings from the Monell Center and Kyushu University report that endocannabinoids act directly on tongue taste receptors to specifically enhance sweet taste. The findings may open doors to the development of new therapeutic compounds to combat obesity and diabetes.
Nine weeks of education about the glycemic index in foods is enough to encourage adults with type 2 diabetes to adopt better dietary habits that result in improvements to their health, recent research suggests.
Individuals who drink more coffee (regular or decaffeinated) or tea appear to have a lower risk of developing type 2 diabetes, according to an analysis of previous studies reported in the December 14/28 issue of Archives of Internal Medicine.
Preparing a healthy meal loaded with fresh vegetables seems like an easy thing to do. But for some people living with diabetes, accessing nutritious food can be difficult --- and may have a detrimental effect on their health and well-being, according to a new Canadian study led by Ryerson University.
In 1999, researchers analyzed 12 years of Los Angeles County death certificates and found that heart attack deaths rise in the balmy Los Angeles winter and peak on Christmas and New Year’s Day. Cardiologist Robert Kloner discusses his research.
The study is designed to determine if diabetic patients exposed to insulin glargine have a higher incidence of cancer than diabetic patients exposed to other insulins or to other glucose-lowering medications.
Pediatric researchers have found that a gene already implicated in the development of type 2 diabetes in adults also raises the risk of being overweight during childhood. The finding sheds light on the genetic origins of diabetes and may present an avenue for developing drugs to counteract type 2 diabetes, currently increasing among youths.
New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with insulin-dependent (type 1) diabetes.
Diabetes is one of the nation’s most prevalent chronic diseases, and Geisinger has created a “bundle” of best practice measures to improve the quality of diabetes care and outcomes.
New Saint Louis University research finds better prognosis for patients with type 2 diabetes and coronary heart disease.
Sinai Hospital of Baltimore takes an innovative approach to help people with diabetes mange their disease by opening the Diabetes Resource Center at Sinai. Participants in programs at this nationally recognized center learn how to achieve successful medical and lifestyle goals.
Women who have gestational glucose intolerance (a condition less severe than gestational diabetes) exhibit multiple cardiovascular risk factors as early as three months after birth, according to a new study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
According to a new study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM), youth with type 1 diabetes have now been found to have abnormal insulin resistance. Having abnormal insulin resistance appears to negatively affect heart, blood vessel and exercise function in this population.
In the next 25 years, the number of Americans living with diabetes will double and spending on diabetes will triple, rising from $113 billion to $336 billion. This will add to the existing strains on an overburdened health care system.
Diabetics face many health challenges, and among them is the risk of developing foot ulcers.
A first-of-its-kind consensus statement on diabetes surgery is published online today in the Annals of Surgery. The report illustrates the findings of the first international consensus conference -- Diabetes Surgery Summit (DSS) -- where an international group of more than 50 scientific and medical experts agreed on a set of evidence-based guidelines and definitions that are meant to guide the use and study of gastrointestinal surgery to treat type 2 diabetes.
Over time, patients with type 2 diabetes lose insulin-producing cells, a difficulty that aggravates their disease. Researchers at Joslin Diabetes Center now have identified a mechanism that triggers the problem, giving a chance to find targets for drugs to protect these crucial cells.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance—a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance—TZDs—alter these same core pathways. This led the team to uncover previously unknown effects of TZDs and insights that could lead to improved drug therapies for insulin resistance.
One out of five Type 2 diabetics is morbidly obese -- approximately 100 pounds overweight -- a Loyola University Health System study has found.
A new survey from the American Diabetes Association asked participants to rank which disease: diabetes, breast cancer or AIDS, was responsible for the largest number of deaths annually.
Columbia University Medical Center will present the 2009 Naomi Berrie Awards to a nationally recognized diabetes researcher, and a promising young investigator, for their outstanding achievements in diabetes research.
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM). This new information is an important step, say researchers, in understanding the role that hormones play in women’s health.
Researchers at the University of Maryland are using the fruit fly, Drosophila melanogaster, as a model system to unravel what genes and gene pathways are involved in the metabolic changes that lead to insulin resistance and full-blown diabetes in humans.
Sustaining modest weight loss for 10 years, or taking an anti-diabetic drug over that time, can prevent or lower the incidence of type 2 diabetes in people at high risk for developing the disease, according to the Diabetes Prevention Program Outcomes Study (DPPOS), a long-term follow-up to a landmark 2001 diabetes prevention study.
Joslin Diabetes Center scientists discover new route by which high blood glucose levels damage eyes.
Cellular phones have taken on many new roles in recent years. Now researchers at Saint Louis University and Old Dominion University say smartphones can be used to help elderly diabetics manage their health and learn more about their condition.
Intensive lifestyle changes aimed at modest weight loss reduced the rate of developing type 2 diabetes by 34 percent over 10 years in people at high risk for the disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right